Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Charles Galanis

Plastic Surgery Beverly Hills, CA Medical Doctor

NPI 1407902190 CMS profile 245800

416 N Bedford Dr Ste 311, Beverly Hills, CA 90210

Open in the dashboard

General payments

$24,082

84 records reported · program years 2019–2025

Research payments

$250

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Charles Galanis of Beverly Hills, CA is reported in the CMS Open Payments database as having received $24,082 across 84 general payments and $250 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 91st percentile of Plastic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,479 9
2024 General $3,735 10
2023 General $18 1
2022 General $11,310 10
2021 General $862 13
2020 General $2,777 11
2020 Research $250 1
2019 General $3,902 30

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Charles Galanis
  • Plastic Surgery median
  • Middle half of Plastic Surgery
  • National median

In program year 2025, general payments to Charles Galanis were reported at $1,479. Among 3,701 Plastic Surgery profiles paid that year, the median was $379 and the middle half received between $138 and $1,100.

Show as a table
Year Charles Galanis Plastic Surgery median Middle half National median
2019 $3,902 $371 $122–$1,483 $163
2020 $2,777 $158 $52–$438 $114
2021 $862 $249 $87–$752 $132
2022 $11,310 $274 $102–$793 $149
2023 $18 $299 $113–$891 $160
2024 $3,735 $361 $124–$1,062 $164
2025 $1,479 $379 $138–$1,100 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Solta Medical, a division of Bausch Health US, LLC $17,591 12 payments
  2. Allergan Inc. $3,238 24 payments
  3. Sientra, Inc. $1,534 12 payments
  4. AbbVie, Inc. $582 11 payments
  5. Apyx Medical Corporation $569 5 payments
  6. Tepha Inc $291 11 payments
  7. Galderma Laboratories, L.P. $95 5 payments
  8. Becton, Dickinson and Company $77 1 payment
  9. Vertex Pharmaceuticals Incorporated $62 2 payments
  10. Motiva USA, LLC $44 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $17,160 5 payments
  2. Food and Beverage $4,222 78 payments
  3. Gift $2,700 1 payment
Products named General payments · program years 2019–2025
  1. NATRELLE $3,070 16 payments
  2. SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT $1,534 12 payments
  3. NATRELLE SALINE-FILLED BREAST IMPLANTS Plastic Surgery $407 10 payments
  4. GalaFLEX $291 11 payments
  5. NATRELLE SALINE-FILLED BREAST IMPLANTS Plastics $93 4 payments
  6. ARISTA $77 1 payment
  7. Motiva Implant Matrix $44 1 payment
  8. BOTOX COSMETIC $35 2 payments
  9. JOURNAVX $31 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Sientra, Inc. $250 1 payment

Records

85 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic Surgery in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record